Increased Output of Recent Thymic Emigrants Contributes to Reconstitution of T‐Cell Pool During Recovery From COVID‐19
11 affiliations
- 1Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- 2Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.
- 3Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- 4Division of Intensive Care Medicine, Department of Anaesthesiology and Intensive Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- 5Faculty of Medicine and Health Technology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa and Tampere University, Tampere, Finland.
- 6Department of Virology, Medicum, Viral Zoonoses Research Unit, University of Helsinki, Helsinki, Finland.
- 7HUSLAB Clinical Microbiology, Division of Virology and Immunology, HUS Diagnostic Center, Helsinki, Finland.
- 8Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
- 9New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- 10Department of Pulmonology, University of Helsinki and Helsinki University Hospital, Meilahti Hospital, Helsinki, Finland.
- 11Helsinki Institute of Life Sciences, HiLIFE, University of Helsinki, Helsinki, Finland.
Abstract
Acute coronavirus disease 2019 (COVID-19) causes marked T-cell lymphopenia, with recovery potentially driven by peripheral proliferation or increased thymic output of recent thymic emigrants (RTEs). We examined the relative contribution of these mechanisms by analyzing naïve T-cell and RTE dynamics in 63 patients sampled at 1-3 timepoints during and after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Overall frequencies of naïve CD4+ and CD8+ T cells remained stable during convalescence. In a female-biased subcohort with paired samples, CD31+ CD4+ and CD21+ CD8+ RTE-enriched subset frequencies increased from acute to late convalescence (LC) stage. Across the full cohort, a significant increase was confirmed for CD21+ CD8+ RTE-enriched subsets. PD-1 and Ki67 expression did not explain this rise, indicating enhancement of thymic output despite the cohort's high median age. Patients requiring ICU care had lower CD31+ CD4+ RTE-enriched subset frequencies in LC compared with non-ICU cases. Regression coefficient modeling identified male sex as a negative predictor of CD31+ CD4+ RTE-enriched subset frequency, potentially contributing to distinct CD31+ CD4+ and CD21+ CD8+ RTE-enriched subset kinetics. Together, these findings suggest that de novo thymic output, particularly CD21+ CD8+ RTE-enriched subset, contributes to T-cell reconstitution after COVID-19 and may influence susceptibility to post-infectious immune dysregulation.
Related
- Transthyretin Contributes to Hippocampal Blood-Brain Barrier Recovery Following Intestinal Inflammation, with Reduced Expression in Alzheimer's Disease
- Effects of brain–computer interface output modalities on motor recovery after stroke: a systematic review and network meta-analysis
- Reconstitution of the Trimethylamine Oxide Reductase Regulatory Elements of Shewanella oneidensis in Escherichia coli
- BCL10 deficiency: Long-term immune reconstitution following hematopoietic stem cell transplantation.
- Immune Reconstitution and Antigenic Exposure History Shape Virus-Specific Humoral Immunity in People with HIV
BibTeX
@article{huang2026increased,
title = {{Increased Output of Recent Thymic Emigrants Contributes to Reconstitution of T‐Cell Pool During Recovery From COVID‐19}},
author = {Xiaobo Huang and Suvi T Jokiranta and Kirsten Nowlan and Ngoc Anh Nguyen and Nelli Heikkilä and Lauriina Tola and Anu Kantele and Pirkka T Pekkarinen and Johanna Hästbacka and Olli Vapalahti and Santtu Heinonen and Juuso Paajanen and Tomas Strandin and Eliisa Kekäläinen},
journal = {European journal of immunology},
year = {2026},
month = oct,
doi = {10.1002/eji.70303},
url = {https://europepmc.org/article/PMC/PMC13718309},
note = {CC BY},
}
RIS
TY - JOUR
TI - Increased Output of Recent Thymic Emigrants Contributes to Reconstitution of T‐Cell Pool During Recovery From COVID‐19
AU - Xiaobo Huang
AU - Suvi T Jokiranta
AU - Kirsten Nowlan
AU - Ngoc Anh Nguyen
AU - Nelli Heikkilä
AU - Lauriina Tola
AU - Anu Kantele
AU - Pirkka T Pekkarinen
AU - Johanna Hästbacka
AU - Olli Vapalahti
AU - Santtu Heinonen
AU - Juuso Paajanen
AU - Tomas Strandin
AU - Eliisa Kekäläinen
PY - 2026
DA - 2026/10/01
JO - European journal of immunology
DO - 10.1002/eji.70303
UR - https://europepmc.org/article/PMC/PMC13718309
AB - Acute coronavirus disease 2019 (COVID-19) causes marked T-cell lymphopenia, with recovery potentially driven by peripheral proliferation or increased thymic output of recent thymic emigrants (RTEs). We examined the relative contribution of these mechanisms by analyzing naïve T-cell and RTE dynamics in 63 patients sampled at 1-3 timepoints during and after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Overall frequencies of naïve CD4+ and CD8+ T cells remained stable during convalescence. In a female-biased subcohort with paired samples, CD31+ CD4+ and CD21+ CD8+ RTE-enriched subset frequencies increased from acute to late convalescence (LC) stage. Across the full cohort, a significant increase was confirmed for CD21+ CD8+ RTE-enriched subsets. PD-1 and Ki67 expression did not explain this rise, indicating enhancement of thymic output despite the cohort's high median age. Patients requiring ICU care had lower CD31+ CD4+ RTE-enriched subset frequencies in LC compared with non-ICU cases. Regression coefficient modeling identified male sex as a negative predictor of CD31+ CD4+ RTE-enriched subset frequency, potentially contributing to distinct CD31+ CD4+ and CD21+ CD8+ RTE-enriched subset kinetics. Together, these findings suggest that de novo thymic output, particularly CD21+ CD8+ RTE-enriched subset, contributes to T-cell reconstitution after COVID-19 and may influence susceptibility to post-infectious immune dysregulation.
SN - 0014-2980
SN - 1521-4141
ER -